Daniel Holder

6.4k citations

74 papers · 4.4k indexed · 2 hit papers · h-index 29

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Statistics and Probability 11
- Statistical Methods in Clinical Trials 10
Virology 6
- HIV Research and Treatment 6

Co-authors: Jon H. Condra (5 shared papers)Anne R. Meibohm (3 shared papers)Emilio A. Emini (4 shared papers)William A. Schleif (3 shared papers)Deborah K. McMahon (2 shared papers)Leslie Jonas (2 shared papers)Jeffrey Chodakewitz (2 shared papers)John W. Mellors (2 shared papers)
Journals: Toxicological Sciences (6 papers)Journal of Alzheimer s Disease (5 papers)Endocrinology (4 papers)Circulation (3 papers)The Journal of Infectious Diseases (3 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Daniel Holder

69 papers receiving 4.2k citations

Hit Papers

align trajectories log scale

Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies 2010 · 520 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 Nature Biotechnology
1997 New England Journal of Medicine

Peers

Countries citing papers authored by Daniel Holder

Since Specialization

Citations

This map shows the geographic impact of Daniel Holder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Holder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Holder more than expected).

Fields of papers citing papers by Daniel Holder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Holder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Holder. The network helps show where Daniel Holder may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Holder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Holder Line = papers co-authored together Daniel Holder links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy New England Journal of Medicine ·Roy M. Gulick, John W. Mellors, Diane V. Havlir, Joseph J. Eron, Charles J. Gonzalez, Deborah K. McMahon, Douglas D. Richman, Fred Valentine, Leslie Jonas, Anne R. Meibohm, Emilio A. Emini, Jeffrey Chodakewitz, Paul Deutsch, Daniel Holder, William A. Schleif, Jon H. Condra Hit paper breakdown →	1997	1531
2	Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies Nature Biotechnology ·Vishal S. Vaidya, Josef Ozer, Frank Dieterle, Fitz B. Collings, Victoria Ramírez, Sean P. Troth, Nagaraja Muniappa, Douglas T. Thudium, David Gerhold, Daniel Holder, Norma A. Bobadilla, Estelle Marrer, Elias Perentes, André Cordier, Jacky Vonderscher, Gerald Maurer, Peter L. Goering, Frank D. Sistare, Joseph V. Bonventre Hit paper breakdown →	2010	520
3	Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases Neuroscience ·H Wang, Hu Sun, Kimberly Della Penna, Robert J Benz, Jing Xu, David Gerhold, Daniel Holder, Kenneth S. Koblan	2002	210
4	Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 Infection JAMA ·Roy M. Gulick, John W. Mellors, Diane V. Havlir, Joseph J. Eron, Charles J. Gonzalez, Deborah K. McMahon, Leslie Jonas, Anne R. Meibohm, Daniel Holder, William A. Schleif, Jon H. Condra, Emilio A. Emini, Robin Isaacs, Jeffrey Chodakewitz, Douglas D. Richman	1998	207
5	Gene Expression Profile of Adipocyte Differentiation and Its Regulation by Peroxisome Proliferator-Activated Receptor-γ Agonists Endocrinology ·David Gerhold, Franklin Liu, Guoqiang Jiang, Zhihua Li, Jian Xu, Meiqing Lu, Jeffrey R. Sachs, Ansuman Bagchi, Arthur Fridman, Daniel Holder, Thomas W. Doebber, Joel P. Berger, Alex Elbrecht, David E. Moller, Bei B. Zhang	2002	158
6	Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury Nature Biotechnology ·Yan Yu, Hong Jin, Daniel Holder, Josef Ozer, Stephanie Villarreal, Paul J. Shughrue, Shi Shu, David J. Figueroa, Holly Clouse, Ming Su, Nagaraja Muniappa, Sean P. Troth, Wendy Bailey, John E. Seng, Amy G. Aslamkhan, Douglas T. Thudium, Frank D. Sistare, David Gerhold	2010	147
7	Identification of Genetic Pathways Activated by the Androgen Receptor during the Induction of Proliferation in the Ventral Prostate Gland Journal of Biological Chemistry ·Pascale V. Nantermet, Jian Xu, Yuanjiang Yu, Paul Hodor, Daniel Holder, Sharon Adamski, Michael A. Gentile, Donald B. Kimmel, Shun-ichi Harada, David Gerhold, Leonard P. Freedman, William J. Ray	2004	96
8	A small sample confidence interval approach to assess individual bioequivalence Statistics in Medicine ·Terry Hyslop, Francis Hsuan, Daniel Holder	2000	84
9	The Use of Strictly Standardized Mean Difference for Hit Selection in Primary RNA Interference High-Throughput Screening Experiments SLAS DISCOVERY ·Xiaohua Douglas Zhang, Marc Ferrer, Amy S. Espeseth, Shane Marine, Erica Stec, Michael A. Crackower, Daniel Holder, Joseph F. Heyse, Berta Strulovici	2007	74
10	Regulation of Gene Expression by Lithium and Depletion of Inositol in Slices of Adult Rat Cortex Neuron ·Philip E. Brandish, Ming Su, Daniel Holder, Paul Hodor, John Szumiloski, Robert Kleinhanz, Jaime E. Forbes, Mollie E. McWhorter, Sven Duenwald, Mark L Parrish, Na Sang, Yuan Liu, Robert L. Phillips, John J. Renger, Sethu Sankaranarayanan, Adam J. Simon, Edward M. Scolnick	2005	69
11	Cerebrospinal Fluid Biomarkers Distinguish Postmortem-Confirmed Alzheimer's Disease from Other Dementias and Healthy Controls in the OPTIMA Cohort Journal of Alzheimer s Disease ·Jeffrey L. Seeburger, Daniel Holder, Marc Combrinck, Catharine Joachim, Omar Laterza, Michael Tanen, Aimée Dallob, Derek L Chappell, Karen Snyder, Mary Flynn, Adam Simon, Vijay Modur, William Z. Potter, Gordon Wilcock, Mary J. Savage, A. David Smith	2015	62
12	MK-507 versus Sezolamide Ophthalmology ·Erik A. Lippa, Joel S. Schuman, Eve J. Higginbotham, Michael A. Kass, Robert N. Weinreb, Gregory L. Skuta, David L. Epstein, Blake R. Shaw, Daniel Holder, Deni A. Deasy, Jacob T. Wilensky	1991	61
13	Neointimal Thickening After Severe Coronary Artery Injury Is Limited by Short-term Administration of a Factor Xa Inhibitor Circulation ·Robert S. Schwartz, Daniel Holder, David R. Holmes, John P. Veinot, Allan R. Camrud, Michael A. Jorgenson, Robert G. Johnson	1996	60
14	Androgen-mediated improvement of body composition and muscle function involves a novel early transcriptional program including IGF1, mechano growth factor, and induction of β-catenin Journal of Molecular Endocrinology ·Michael A. Gentile, Pascale V. Nantermet, Robert L. Vogel, Robert Phillips, Daniel Holder, Paul Hodor, Chun Cheng, Hongyue Dai, Leonard P. Freedman, William J. Ray	2009	59
15	Androgenic Induction of Growth and Differentiation in the Rodent Uterus Involves the Modulation of Estrogen-Regulated Genetic Pathways Endocrinology ·Pascale V. Nantermet, P. Masarachia, Michael A. Gentile, Brenda L Pennypacker, Jian Xu, Daniel Holder, David Gerhold, Dwight A. Towler, Azriel Schmidt, Donald B. Kimmel, Leonard P. Freedman, Shun-ichi Harada, William J. Ray	2004	58
16	Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients The Journal of Infectious Diseases ·Cameron Douglas, R. Barnard, Daniel Holder, Randi Y. Leavitt, Diane Levitan, Maureen G. Maguire, David C. Nickle, Valerie Teal, Hong Wan, Dirk C.J.G. van Alewijk, Leen‐Jan van Doorn, Sunwen Chou, Julie Strizki	2019	57
17	The Enhanced Contractility of the Phospholamban-deficient Mouse Heart Persists with Aging Journal of Molecular and Cellular Cardiology ·J. P. Slack, Ingrid L. Grupp, R. Dash, Daniel Holder, Albrecht Schmidt, Michael Gerst, Tetsutaro Tamura, Carola Tilgmann, Paul F. James, Robert C. Johnson, Anne‐Marie Gerdes, Evangelia G. Kranias	2001	55
18	Factors Influencing the Emergence of Resistance to Indinavir: Role of Virologic, Immunologic, and Pharmacologic Variables The Journal of Infectious Diseases ·George L. Drusano, John A. Bilello, Daniel S. Stein, Michael L. Nessly, Anne R. Meibohm, Emilio A. Emini, Paul Deutsch, Jon H. Condra, J Chodakewitz, Daniel Holder	1998	52
19	Effects of Subtype-Selective and Balanced Angiotensin II Receptor Antagonists in a Porcine Coronary Artery Model of Vascular Restenosis Circulation ·William R. Huckle, Marlene Drag, Wayne R. Acker, Michele Powers, Rosemary C. McFall, Daniel Holder, Tsuneo Fujita, Inez I. Stabilito, Dooseop Kim, Debra L. Ondeyka, Nathan B. Mantlo, Raymond S.L. Chang, Christopher Reilly, Robert S. Schwartz, William J. Greenlee, Robert Garret Johnson	1996	52
20	Evaluation of the Relative Performance of 12 Urinary Biomarkers for Renal Safety Across 22 Rat Sensitivity and Specificity Studies Toxicological Sciences ·Kateřina Vlasáková, Zoltán Erdős, Sean P. Troth, Kathleen A. McNulty, Valérie Chapeau-Campredon, Nathalie Mokrzycki, Nagaraja Muniappa, Yi‐Zhong Gu, Daniel Holder, Wendy J. Bailey, Frank D. Sistare, Warren E. Glaab	2013	51

About Daniel Holder

Daniel Holder is a scholar working on Statistics and Probability, Virology, Space and Planetary Science, Nephrology and Small Animals, having authored 74 papers that have together received 4.4k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (10 papers), HIV Research and Treatment (6 papers), Alzheimer's disease research and treatments (5 papers), HIV/AIDS drug development and treatment (5 papers), Molecular Biology Techniques and Applications (5 papers), HIV/AIDS Research and Interventions (4 papers), Acute Kidney Injury Research (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). The work is most often cited by research in Virology (1.5k citations), Infectious Diseases (1.6k citations), Nephrology (398 citations), Emergency Medicine (212 citations) and Statistics and Probability (170 citations). Daniel Holder has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Jon H. Condra, Anne R. Meibohm, Emilio A. Emini, William A. Schleif, Deborah K. McMahon, Leslie Jonas, Jeffrey Chodakewitz, John W. Mellors, Joseph J. Eron and Diane V. Havlir. Their work appears in journals such as Toxicological Sciences, Journal of Alzheimer s Disease, Endocrinology, Circulation and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact